Search

everythinglearnresearchcommunity

for

Search:↓

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Mice with human gene experienced hair loss when treated with DHT.

People often have negative attitudes toward those with alopecia, especially if it's severe or seen as a medical issue.

WAA-QOL measures impact of hair loss on women's well-being.

UV rays can cause a type of hair loss known as telogen alopecia.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

Model improves accuracy in predicting hair loss effects.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Hair transplantation is the best treatment for hair loss, with new technologies improving results, and stem cell and gene therapies may treat severe baldness in the future.

Videodermoscopy is effective for diagnosing different types of non-scarring hair loss.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Finger length ratio may indicate male hair loss.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Combining oral methylprednisolone with microneedle radiofrequency improves hair growth in alopecia areata but may cause pain and side effects.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

New grading scale accurately measures hair loss severity and treatment effectiveness.

The MPV/PC ratio can help assess disease activity in alopecia areata.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.